Growing community of inventors

New York, NY, United States of America

Michael S Weiss

Average Co-Inventor Count = 4.10

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Michael S Weiss ↔ Peter Sportelli (4 patents)Michael S Weiss ↔ Hari P Miskin (3 patents)Michael S Weiss ↔ Swaroop K V S Vakkalanka (2 patents)Michael S Weiss ↔ George Costas Avgerinos (1 patent)Michael S Weiss ↔ Patrick Michael Hossler (1 patent)Michael S Weiss ↔ Yune Z Kunes (1 patent)Michael S Weiss ↔ Jill A Myers (1 patent)Michael S Weiss ↔ Sri Hari Pandurang Miskin (1 patent)Michael S WeissMichael S Weiss (4 patents)Peter SportelliPeter Sportelli (4 patents)Hari P MiskinHari P Miskin (3 patents)Swaroop K V S VakkalankaSwaroop K V S Vakkalanka (6 patents)George Costas AvgerinosGeorge Costas Avgerinos (4 patents)Patrick Michael HosslerPatrick Michael Hossler (4 patents)Yune Z KunesYune Z Kunes (4 patents)Jill A MyersJill A Myers (4 patents)Sri Hari Pandurang MiskinSri Hari Pandurang Miskin (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Laboratoire Francais Du Fractionnement Et Des Biotechnologies (4 from 85 patents)

2. Tg Therapeutics, Inc. (4 from 7 patents)

3. Rhizen Pharmaceuticals Sa (2 from 51 patents)

4. Rhizen Pharmaceuticals Na (1 from 1 patent)


4 patents:

1. 11814439 - Anti-CD20 antibody compositions

2. 10966977 - Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders

3. 10729768 - Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

4. 9694071 - Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…